NVS
Novartis AG ADRNYSE
Healthcare • Drug Manufacturers - General
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Momentum Mega Cap
$142.41-0.99%
Close Oct 13, 2026
- Market cap
- $272.57B
- 1 month
- +2.5%
- 3 months
- -5.6%
- 1 year
- +9.5%
- 52-week range
- $121.80$168.62
- Dividend, last 12 mo
- $4.7402 · 3.33% yield
- Last ex-date
- Mar 11, 2026 · $4.7402
- Dividend growth
- 5+ years in a row
- Short interest
- 0.3% of float5.6M shares · settled Sep 30, 2026 · +8.2% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if NVS is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
219 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
1,627 filers reported a long position in NVS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Fisher Asset Management, LLC | $2.4B | 15.5M | +11.8% |
| MORGAN STANLEY | $1.4B | 8.7M | +2.3% |
| DIMENSIONAL FUND ADVISORS LP | $1.3B | 8.1M | +0.1% |
| PRIMECAP MANAGEMENT CO/CA/ | $1B | 6.6M | -12.9% |
| LOOMIS SAYLES & CO L P | $821.1M | 5.2M | -3.4% |
| BANK OF AMERICA CORP /DE/ | $769.5M | 4.9M | -1.1% |
| FRANKLIN RESOURCES INC | $509.5M | 3.3M | -4.7% |
| BlackRock, Inc. | $477.7M | 3M | +3.3% |
| GOLDMAN SACHS GROUP INC | $467.1M | 3M | -54.3% |
| NORTHERN TRUST CORP | $437.7M | 2.8M | +0.2% |
Get the Full Analysis for NVS
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.